DZIP3 and breast carcinoma: Although GAIT activity has not been demonstrated in other cell types, including breast cancer cells, several genes predicted to be regulated by GAIT, such as RORA, NRIP1, and DZIP3 have been shown to mediate ERα-dependent proliferation of breast cancer cells [34–39].